Aditxt ( (ADTX)) just unveiled an announcement. On July 8, 2025, Amro Albanna, CEO of Aditxt, Inc., presented at Wall Street Reporter’s Next Super Stock livestream event, discussing the company’s ...

Windtree serves as Evofem's sourcing partner for PHEXXI under the company's March 2025 License and Supply Agreement. About Windtree Therapeutics, Inc.

Windtree Therapeutics said it has contracted with a pharmaceutical manufacturer in China to produce Evofem Biosciences's hormone-free contraceptive product Phexxi at a low cost.

Windtree serves as Evofem’s sourcing partner for PHEXXI under the company’s March 2025 License and Supply Agreement. About Windtree Therapeutics, Inc. Windtree Therapeutics, Inc. is a diversified ...

Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut PHEXXI manufacturing costs by over 50% by end of ...

The closing of the transaction with Evofem is subject to several conditions, including but not limited to approval of the transaction by Evofem’s shareholders and Aditxt raising sufficient ...

Windtree serves as Evofem’s sourcing partner for PHEXXI under the company’s March 2025 License and Supply Agreement. About Windtree Therapeutics, Inc.

The companies are working toward a targeted close in the second half of 2025. The closing of the transaction with Evofem is subject to several conditions, including but not limited to approval of the ...

(RTTNews) - Evofem Biosciences, Inc. (EVFM) Monday said that Pharma 1 Drug Store LLC has submitted an application to the United Arab Emirates (UAE) Ministry of Health and Prevention (MOHAP ...